Study of pro- and anti-oxidative properties of D-penicillamine in a system comprising high-molar-mass hyaluronan, ascorbate, and cupric ions

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 697-701

  Valachová, Katarína ^a   Hrabárová, Eva ^b   Gemeiner, Peter ^b   Šoltés, Ladislav ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Ascorbic acid (vitamin C); Copper (II); D penicillamine; Disease modifying anti rheumatoid drug; Hyaluronan degradation; Immunomodulating drug; Neurodegenerative disorders; Reactive oxygen species; Rotational viscometry; Wilson's disease

Indexed keywords

ASCORBIC ACID; CUPRIC ION; HYALURONIC ACID; HYDROXYL RADICAL; PENICILLAMINE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DEGRADATION KINETICS; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; MOLECULAR WEIGHT; RADICAL REACTION; REACTION TIME; VISCOMETRY;

EID: 57149130274     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology. 2003; 189:147-163.
2. Williams KM. Enantiomers in arthritic disorders. Pharmacology & Therapeutics. 1990; 46: 273-295.
3. Niedermeier W, Griggs JH. Trace metal composition of synovial fluid and blood serum of patients with rheumatoid arthritis. Journal of Chronic Diseases. 1971; 23: 527-536.
4. Staite ND, Messner RP, Zoschke DC. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability. Arthritis & Rheumatism. 2005; 28: 914-921.
5. Hardingham T. Solution properties of hyaluronan. In Chemistry and Biology of Hyaluronan; Garg, H. G., Hales, C. A., Eds.; Elsevier Press: Amsterdam, 2004; pp 1-19.
6. Šoltás L, Mendichi R, Kogan G, Schiller J, Stankovská M, Arnhold J. Degraclative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006; 7: 659-668.
7. Rychlý J, Šoltés L, Stankovská M, Janigová I, Csomorová K, Sasinková V, Kogan G, Gemeiner P. Unexplored capabilities of chemiluminescence and thermoanalytical methods in characterization of intact and degraded hyaluronans. Polymer Degradation and Stability. 2006; 91: 3174-3184.
8. Valachová K, Kogan G, Gemeiner P, Šoltés L. Hyaluronan degradation by ascorbate: protective effects of manganese(II) chloride. In: "Progress in Chemistry and Biochemistry. Kinetics, Thermodynamics, Synthesis, Properties and Application." Pierce E. (ed.), Nova Science Publishers, New York 2008.
9. Šoltés L, Stankovská M, Kogan G, Mendichi R, Volpi N, Sasinková V, Gemeiner P. Degradation of high-molar-mass hyaluronan by an oxidative system comprising ascorbate, Cu(II), and hydrogen peroxide: Inhibitory action of antiinflammatory drugs - Naproxen and acetylsalicylic acid. Journal of Pharmaceutical and Biomedical Analysis. 2007; 44: 1056-1063.
10. Stankovská M, Šoltaces L, Vikartovské A, Mendichi R, Lath D, Molnárovaca M, Gemeiner P. Study of hyaluronan degradation by means of rotational viscometry: Contribution of the material of viscometer. Chemical Papers. 2004; 58: 348-352.
11. Šoltés L, Valachové K, Mendichi R, Kogan G, Arnhold J, Gemeiner P. Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate. Carbohydrate Research. 2007; 342: 1071-1077.
12. Stankovská M, Hrabárová E, Valachová K, Molnárová M, Gemeiner P, Šoltés L. The degradative action of peroxynitrite on high-molecular-weight hyaluronan. Neuro Endocrinology Letters. 2006; 27 Suppl 2:31-34.
13. Ionescu JG, Novotny J, Stejskal V, Lätsch A, Blaurock-Busch E, Eisenmann-Klein M. Increased levels of transition metals in breast cancer tissue. Neuro Endocrinology Letters. 2006; 27 Suppl 1:36-39.